Skip to main content
Clinical Trials/NCT01443585
NCT01443585UnknownNot Applicable

Clinical Performance Evaluation of a Progressive Addition Lens Among Presbyopic Patients

Ziv Hospital0 sites100 target enrollmentStarted: September 1, 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
100
Primary Endpoint
Horizontal Intermediate Visual Field

Study Overview

Brief Summary

The purpose of the trial is to clinically evaluate the performance of a progressive addition lens among presbyopic patients.

This evaluation will be done by performing visual tests and collecting subjective information from subjects wearing the lens which will be manufactured according to personal prescription.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • An ability to comprehend and give an informed consent for participation in the trial
  • Presbyopia

Exclusion Criteria

  • Concurrent participation in another clinical trial
  • For female subjects: pregnancy \ planning a pregnancy \ lactating at the time of enrollment
  • Imbalanced diabetes \ high blood pressure \ thyroid disease
  • Infectious disease
  • Inability (cognitively) to comprehend the instructions given during the trial and to comply with them

Outcomes

Primary Outcomes

Horizontal Intermediate Visual Field

Time Frame: Baseline

Visual Acuity

Time Frame: Baseline

Horizontal Near Visual Field

Time Frame: Baseline

Field of comfortable reading on a computer screen

Time Frame: Baseline

Horizontal Far Visual Field

Time Frame: Baseline

Secondary Outcomes

  • Subjective Evaluation of Visual Quality(2-3 weeks)
  • Overall Subjective Feedback(2-3 weeks)

Investigators

Sponsor
Ziv Hospital
Sponsor Class
Other Gov
Responsible Party
Sponsor

Similar Trials